Related by context. All words. (Click for frequent words.) 66 chronic granulomatous disease 64 Gleevec resistant 64 metastatic uveal melanoma 64 idiopathic thrombocytopenic purpura ITP 64 myeloproliferative disorder 63 metastatic malignant 63 MELAS 63 dyskeratosis congenita 63 LHON 63 anti CD3 antibody 62 Symadex 62 Leber Hereditary Optic Neuropathy 62 ADPKD 62 renal fibrosis 62 Glioblastoma Multiforme 62 thalidomide Thalomid 62 lung fibrosis 61 leukemia ALL 61 cytopenia 61 pancytopenia 61 idiopathic pulmonary fibrosis IPF 61 leukoencephalopathy 61 atypical hemolytic uremic syndrome 61 SSc 61 lymphocytic leukemia 61 gastrointestinal stromal tumor 61 Aviptadil 61 antibody mediated 61 hematologic disorders 61 myeloid metaplasia 61 leukemia CML 61 neuronal dysfunction 61 gefitinib Iressa 61 nonhuman primate model 61 PTLD 61 ductal adenocarcinoma 60 Alzheimer Disease AD 60 diffuse intrinsic pontine glioma 60 optica 60 Aplidin 60 lung metastasis 60 PDE# inhibitors 60 gastrointestinal stromal tumors GISTs 60 allograft rejection 60 leukemia AML 60 Myelodysplastic Syndrome MDS 60 hypereosinophilic syndrome 60 depsipeptide 60 neurological manifestations 60 ependymoma 60 Chronic lymphocytic leukemia 60 paroxysmal nocturnal hemoglobinuria 60 fibrotic disease 60 malignant lymphomas 60 monogenic 60 Omacetaxine 60 glomerulonephritis 60 diabetic retinopathy DR 60 recurrent glioblastoma multiforme 60 kidney urologic 60 rituximab Rituxan 60 lysosomal storage disease 60 PAOD 60 denileukin diftitox 60 apoptotic pathway 60 idiopathic thrombocytopenic purpura 60 Alequel 60 MGd 60 autosomal dominant polycystic kidney 60 pulmonary metastasis 60 neurotrophic 60 immune thrombocytopenic purpura ITP 60 uPA 59 colorectal carcinoma 59 tumorigenicity 59 gastrointestinal stromal tumors GIST 59 chemoresistance 59 tuberous sclerosis complex 59 imatinib resistance 59 receptor tyrosine kinase inhibitor 59 myeloproliferative disorders 59 biliary tract cancer 59 myeloproliferative 59 pancreatic adenocarcinoma 59 neovascularisation 59 systemic amyloidosis 59 haematopoietic 59 IL 1ß 59 bullous 59 gastrointestinal stromal tumor GIST 59 chronic thromboembolic pulmonary 59 Vidaza azacitidine 59 hyperparathyroidism 59 hyperprolactinemia 59 cerebral vasospasm 59 2DG 59 cutaneous lupus 59 progressive neurodegenerative 59 remyelination 59 familial hypercholesterolemia FH 59 pancreatic ductal adenocarcinoma 59 transplantation HCT 59 juvenile idiopathic arthritis JIA 59 dilated cardiomyopathy DCM 59 Hepatocellular Carcinoma HCC 59 hepatic cirrhosis 59 bortezomib Velcade 59 riociguat 59 TTR amyloidosis 59 MPGN 59 type 1diabetes 59 urothelial cancer 59 autoinflammatory diseases 59 AA amyloidosis 59 squamous cell lung cancer 59 CRVO 59 ANCA associated 59 proliferative retinopathy 59 thyroid carcinoma 59 progressive neurodegenerative disorder 59 Acute Myelogenous Leukemia AML 59 membranous nephropathy 59 ischemia induced 59 hepatic toxicity 59 idiopathic pulmonary 59 erlotinib Tarceva 59 GW# [003] 59 JMML 59 chronic eosinophilic leukemia 59 Idiopathic Pulmonary Fibrosis IPF 59 mTOR inhibitors 59 Dacogen decitabine 59 Gleevec imatinib mesylate 59 diagnostic biomarker 59 Cloretazine 59 fibrogenesis 59 lumiliximab 59 polycythemia vera essential thrombocythemia 59 epithelial tumors 59 gastric adenocarcinoma 59 Gleevac 59 papillary renal cell carcinoma 58 Six3 58 gastric carcinoma 58 acute myelogenous leukemia AML 58 pharmacological chaperone 58 vivo validation 58 OHR/AVR# 58 invasive candidiasis 58 Chronic pancreatitis 58 myotonic muscular dystrophy 58 systemic mastocytosis 58 Enzastaurin 58 Fingolimod 58 psoriatic arthritis PsA 58 antimetastatic 58 chronic GVHD 58 chronic myeloid 58 systemic lupus erythematosus 58 recurrent glioblastoma multiforme GBM 58 ATTR CM 58 SNT MC# 58 Systemic lupus erythematosus SLE 58 T1DM 58 Cryptococcus neoformans 58 antiangiogenic agent 58 pemphigus vulgaris 58 tafamidis 58 Pseudomonas aeruginosa infections 58 cAMP signaling 58 colorectal adenocarcinoma 58 leukocyte adhesion 58 Annamycin 58 experimental autoimmune encephalomyelitis 58 lymphangiogenesis 58 diabetic gastroparesis 58 atypical rhabdoid tumor 58 chronic myocardial ischemia 58 complement inhibitor eculizumab 58 granulomatous 58 thyroid tumors 58 systemic fungal infections 58 Parkinson disease PD 58 Glioblastoma Multiforme GBM 58 multiple myeloma MM 58 PhG alpha 1 58 RhuDex 58 Ph + acute lymphoblastic 58 neuroinflammatory 58 neuroendocrine cancers 58 recurrent glioblastoma 58 Hydroxyurea 58 anti angiogenic therapy 58 myeloproliferative diseases 58 Hereditary angioedema 58 lomitapide 58 pediatric acute lymphoblastic 58 Rituxan rituximab 58 uricase 58 AA Amyloidosis 58 vaso occlusive crisis 58 miglustat 58 Gorlin syndrome 58 RNAi therapeutic targeting 58 cytomegalovirus infection 58 Leber congenital amaurosis 58 PARP inhibition 58 severe malignant osteopetrosis 58 AML acute myeloid 58 alagebrium 58 Velcade bortezomib 58 airway hyperresponsiveness 58 immunopathology 58 carcinoid 58 MALT lymphoma 58 cardiac repolarization 58 pheochromocytoma 58 antiproliferative effects 58 malignant transformation 58 thymoma 58 BZL# 58 PKC beta 58 alkylating agent 58 ATTR PN 58 Aflibercept 58 refractory Hodgkin 58 BrachySil ™ 58 NPHP 58 pancreatic islet cell 58 basophils 58 Gleevec imatinib 58 immunosuppressant drug 58 malignant ascites 58 Myelodysplastic Syndrome 57 monocytes macrophages 57 cystic fibrosis chronic pancreatitis 57 Eisenmenger syndrome 57 Ribavirin causes 57 hypophosphatasia 57 HER2 overexpression 57 relapsed leukemia 57 Wegener Granulomatosis 57 neovascularization 57 transgenic rats 57 chronic myelogenous leukemia CML 57 Nexavar sorafenib 57 leukoencephalopathy PML 57 Systemic Lupus Erythematosus 57 flavopiridol 57 metastatic gastric 57 eosinophilic asthma 57 Hematologic 57 Certolizumab pegol 57 Panzem 57 paraganglioma 57 Waldenstrom macroglobulinemia 57 Dasatinib 57 NAGS deficiency 57 FLT3 57 cholangiocarcinoma 57 alpha1 antitrypsin deficiency 57 sitaxsentan 57 cisplatin resistant 57 retinal degenerative disease 57 Duchenne muscular dystrophy DMD 57 demonstrated antitumor activity 57 lesional 57 1 diabetes T1D 57 cystic lesions 57 immunodeficiency disorders 57 polymicrobial infections 57 progressive multifocal PML 57 Chronic lymphocytic leukemia CLL 57 interstitial pneumonitis 57 Lupus nephritis 57 obliterative bronchiolitis 57 precancerous condition 57 GIST tumors 57 chromosomal translocation 57 Atypical Hemolytic Uremic Syndrome 57 systemic scleroderma 57 Troxatyl 57 heterozygous FH 57 sJIA 57 veno occlusive disease 57 Teriflunomide 57 commercialize deforolimus 57 acute leukemia AML 57 discoid lupus 57 diabetes mellitus DM 57 pemetrexed Alimta 57 Lafora disease 57 GRNCM1 57 MGUS 57 hereditary spastic paraplegia 57 Pulmonary hypertension 57 juvenile myelomonocytic leukemia 57 Zybrestat 57 Chronic myeloid leukemia 57 mGluR2 NAM 57 primary hyperparathyroidism 57 imatinib therapy 57 immunosuppressive medication 57 Behcet disease 57 trial evaluating PRX# 57 Nuvion 57 interstitial pneumonia 57 pulmonary hypertension PH 57 autologous transplants 57 Squalamine 57 multicenter Phase II 57 renal carcinoma 57 interstitial nephritis 57 mutated KRAS 57 TYSABRI natalizumab 57 parkinsonian symptoms 57 transplantation HSCT 57 vemurafenib 57 demyelinating 57 COX2 57 fibrosarcoma 57 thrombotic thrombocytopenic purpura 57 homozygous FH 57 neuro degenerative disease 57 congenita 57 immunomodulatory therapy 57 neuronal ceroid lipofuscinosis 57 polymorphic ventricular tachycardia 57 myelogenous leukemia 57 lymphoid malignancies 57 beta1 integrin 57 histone deacetylase inhibitor 57 squamous cell carcinoma SCC 57 cardiac dysfunction 57 post transplant lymphoproliferative 57 pertuzumab 57 LPS induced 57 chronic rheumatic 57 Ataluren 57 CEQ# 57 lenalidomide dexamethasone 57 allogeneic bone marrow 57 LPA1 receptor 57 erythropoiesis 57 CA4P 57 immune modulator 57 neoplastic cells 57 Uricase PEG 57 Occlusive Disease 57 portal vein thrombosis 57 Sutent sunitinib 57 alpha#beta# integrin 57 IVIG therapy 57 VEGF induced 57 refractory gout 57 acute lymphoblastic 57 fosbretabulin 57 synaptogenesis 57 alveolar rhabdomyosarcoma 57 systemic sclerosis SSc 57 infantile spasms 57 Hashimoto thyroiditis 57 Stargardt Macular Dystrophy 57 angiosarcoma 57 infective endocarditis 57 Leukemias 57 hypervascular tumors 57 leukaemic stem cells 57 Proxinium TM 57 murine model 57 lupus nephritis 57 thromboembolic disease 57 Parkinsons disease 57 rheumatic disease 57 Idiopathic Thrombocytopenic Purpura ITP 57 alcoholic hepatitis 57 Bezielle 57 plasma kallikrein 57 leukemia CLL 57 neurogenic bladder 57 metastatic neuroendocrine tumors 57 embolic stroke 56 IgG1 antibody 56 Kit CD# positive 56 HNSCC 56 LPLD 56 carcinoid tumors 56 intravascular hemolysis 56 Pemphigus 56 Zenapax 56 antiangiogenic drugs 56 inhibit metastasis 56 systemic lupus erythematosus SLE 56 embryonal rhabdomyosarcoma 56 nonalcoholic steatohepatitis NASH 56 diabetes mellitus T2DM 56 Idiopathic Pulmonary Fibrosis 56 EVIZON TM 56 Bucindolol 56 hematological diseases 56 etanercept Enbrel 56 treat chronic sinusitis 56 pharmacologic intervention 56 hormonal disorder 56 pulmonary arterial hypertension PAH 56 diabetic kidney 56 mTOR mammalian target 56 HeFH 56 Candida infection 56 Myelodysplastic syndrome 56 polycythemia vera PV 56 hepatocellular carcinoma 56 haematological malignancies 56 Beta thalassemia 56 malignant pleural mesothelioma 56 G6PD deficiency 56 smoldering myeloma 56 cytopenias 56 Hodgkin lymphoma HL 56 insulitis 56 dyskinetic 56 Phenylketonuria PKU 56 atypical Hemolytic Uremic Syndrome 56 genomic biomarker 56 recessive dystrophic epidermolysis bullosa 56 TMS Therapy 56 allogeneic HSCT 56 imatinib resistant 56 Huntingtons disease 56 Hepatotoxicity 56 Veno Occlusive Disease 56 receptor inhibitor 56 basiliximab 56 occlusive disease 56 INCB# [003] 56 non alcoholic steatohepatitis 56 anti fibrotic 56 lymphomas leukemias 56 trastuzumab Herceptin ® 56 dexanabinol 56 BCR ABL inhibitor 56 Sudhir Agrawal D.Phil 56 inflammatory demyelinating 56 skeletal sarcomere activator 56 bevacizumab Avastin ® 56 Liver transplantation 56 lymphoblastic leukemia 56 valvular heart disease 56 neuronal differentiation 56 congenital blindness 56 Severe Primary IGFD 56 hereditary deafness 56 acute GvHD 56 myasthenia gravis MG 56 androgen ablation 56 ADAMTS# 56 levodopa induced 56 Rheumatoid Arthritis RA 56 MYCN amplification 56 E selectin 56 Systemic Lupus Erythematosus SLE 56 Bosentan 56 lymphoid cells 56 CTEPH 56 autoimmune encephalitis 56 myelodysplasia 56 degenerative retinal diseases 56 Degarelix 56 neuro endocrine 56 myelodysplastic myeloproliferative diseases 56 medically refractory 56 thyrotoxicosis 56 Aortic stenosis 56 cardiac allograft vasculopathy 56 Onglyza saxagliptin 56 neovascular 56 pancreatitis inflammation 56 colon carcinoma 56 GGF2 56 cortical dysplasia 56 ENMD # 56 hepatic fibrosis 56 neuron degeneration 56 myotonic dystrophy 56 antiphospholipid syndrome APS 56 PPAR gamma agonist 56 TTR gene 56 Revlimid lenalidomide 56 demyelinating disease 56 Behcet uveitis 56 ischemic mitral regurgitation 56 SGS# 56 tumor regressions 56 liver decompensation 56 protein misfolding diseases 56 ankylosing spondylitis AS 56 NQO1 56 ara C 56 Leber Congenital Amaurosis LCA 56 enterocolitis 56 tyrosine kinase inhibitors TKIs 56 hyperoxaluria 56 retinal degeneration 56 Fabry Disease 56 dasatinib Sprycel 56 hereditary predisposition 56 TTF Therapy 56 DFMO 56 efalizumab 56 Myelofibrosis 56 proliferative diabetic retinopathy 56 Clusterin 56 Lennox Gastaut Syndrome 56 haematologic 56 refractory acute myeloid 56 necrotizing 56 nasopharyngeal carcinoma 56 Safinamide 56 xeroderma pigmentosum 56 potent antiproliferative 56 Staphylococcus aureus infections 56 hyperinsulinemia 56 spinal muscular atrophy SMA 56 neoadjuvant setting 56 acute myeloid 56 DCVax 56 Kepivance 56 neurodegenerative disorder 56 inherited retinal degeneration 56 adult mesenchymal stem 56 hepatocellular carcinoma HCC 56 Tykerb lapatinib 56 Lennox Gastaut syndrome 56 extramedullary 56 Anthracycline 56 dominantly inherited 56 lenalidomide Revlimid 56 hypothalamic pituitary adrenal axis 56 hour bronchodilation 56 patientswith 56 colorectal cancer liver metastases 56 astrocytomas 56 pediatric Crohn disease 56 periodontal tissues 56 Xanafide 56 Philadelphia Chromosome Positive 56 CVBT #H 56 schizophrenia CIAS 56 treatmentof 56 Graft Versus Host 56 hedgehog pathway 56 Prestara 56 ALK inhibitors 56 Langerhans cell histiocytosis 56 erythropoietic 56 Phase Ib clinical 56 DIPG 56 Neurofibromatosis Type 56 CMV infections 56 lupus multiple sclerosis 56 V#F mutation 56 Cockayne syndrome 56 renal kidney 56 Akt activation 56 TACI Ig 56 NF kB pathway 56 BrachySil TM 56 prematurity ROP 56 CytoFabTM 56 nonsense mutation 56 thymic carcinoma 55 Zarnestra 55 recurrent metastatic 55 tramiprosate 55 hemolytic anemia 55 cardiac hypertrophy 55 anti angiogenic agents 55 Interferon beta 55 Valproic acid 55 vasculopathy 55 phase IIb clinical 55 midstage trials 55 gallium nitrate 55 Telintra 55 tumors GIST 55 meningeal 55 ACV1 55 Morquio 55 coronary artery atherosclerosis 55 mastocytosis 55 metastatic ovarian cancer 55 Alport syndrome 55 antiangiogenic therapy 55 IRS1 55 enteroviral infection 55 nerve degeneration 55 presymptomatic 55 variceal bleeding 55 inducible nitric oxide synthase 55 transgenic mouse models 55 diabetic nephropathy 55 Sprycel dasatinib 55 acinar cells 55 Hurler syndrome 55 Neurofibromatosis type 55 cMET 55 hepatic encephalopathy HE 55 Leydig cell 55 proliferative disorders 55 angiogenesis inhibition 55 immunocompetent 55 chronic lymphocytic leukemia CLL 55 Chronic Lymphocytic Leukemia CLL 55 MAPK pathway 55 Friedreich 55 facioscapulohumeral muscular dystrophy 55 nephritis 55 Fibroblast 55 Hypotension 55 Tocosol Paclitaxel 55 cirrhosis liver failure 55 candidemia 55 Epstein Barr virus EBV 55 rALLy clinical trial 55 proteasome inhibitor 55 hemophagocytic lymphohistiocytosis 55 neovascular diseases 55 thetreatment 55 IGFD 55 node metastasis 55 inherited neurodegenerative disorder 55 synovial cells 55 Mutation Analysis 55 Cholangiocarcinoma 55 sorafenib Nexavar 55 syngeneic 55 MyVax 55 Cyclosporin 55 pig islets 55 Myelodysplastic syndromes MDS 55 beta interferons 55 YONDELIS 55 TKI therapy 55 essential thrombocythemia 55 ELACYT 55 motor neuron diseases 55 ruboxistaurin 55 factor TNF 55 cancerdefine 55 IFN beta 55 selective inhibition 55 Waldenstrom Macroglobulinemia 55 metastatic lung cancer 55 treating neuropathic pain 55 secondary hyperparathyroidism 55 skeletal metastases 55 Inhaled nitric oxide 55 Catena ® 55 EGFR tyrosine kinase inhibitors 55 cardiac infarction 55 beta 1a 55 cardiotoxic 55 metastatic malignant melanoma 55 Evoltra TM 55 p# activation 55 myeloablative 55 JAK2 enzyme 55 Mitomycin C 55 fatal neurodegenerative disorder 55 hypoperfusion 55 induces apoptosis 55 targeted antifolate 55 acute promyelocytic leukemia 55 prostate adenocarcinoma 55 carcinoid tumor 55 glioblastoma tumors 55 vestibular schwannomas 55 aortic valve stenosis 55 alefacept 55 serous ovarian cancer 55 esophageal candidiasis 55 oncogenesis 55 immunomodulation 55 tachyarrhythmias 55 Inflammatory bowel diseases 55 visilizumab 55 PKC# 55 Eculizumab 55 durable remissions 55 leukemias lymphomas 55 VA# [002] 55 Barrett esophagus BE 55 endotoxemia 55 LHRH receptor positive 55 haematologic malignancies 55 ischemic colitis 55 Pamidronate 55 hematological malignancy 55 Crohns disease 55 Cell Lymphoma CTCL 55 FVIII inhibitors 55 Epstein Barr Virus EBV 55 Friedreich ataxia 55 urothelial carcinoma 55 Leber congenital amaurosis LCA 55 optic neuropathy NAION 55 ERK signaling 55 hypomethylation 55 microvascular dysfunction 55 antiphospholipid syndrome 55 IMA# 55 SNT-MC#/idebenone 55 hematopoietic cell 55 vascular insufficiency 55 adrenocortical cancer 55 Noxafil 55 EGFR inhibitors 55 transthyretin amyloidosis 55 Raynaud syndrome 55 CMV vaccine 55 mesenchymal cell 55 Haptoglobin 55 polyposis 55 GISTs 55 bladder ovarian 55 chemoresistant 55 proto oncogene 55 Retinitis Pigmentosa RP 55 β thalassemia 55 HQK 55 malignant pheochromocytoma 55 abnormal angiogenesis 55 esophageal squamous cell carcinoma 55 Etanercept 55 overt nephropathy 55 PC# cells 55 myoclonus 55 MYLOTARG 55 IDDM 55 vidofludimus 55 terlipressin 55 idiopathic myelofibrosis 55 Nephrotic Syndrome 55 Monoclonal antibody 55 Ceflatonin 55 Relapsing remitting MS 55 gonococcal 55 IRX 2 55 malignant pancreatic 55 juvenile idiopathic arthritis 55 GBM tumors 55 BioNumerik 55 RRM1 55 immunological diseases 55 TET2 55 Hedgehog Pathway Inhibitor 55 multiorgan 55 HGPS 55 hepatorenal syndrome 55 cetuximab Erbitux ® 55 cell lymphoma CTCL 55 Enzyme Replacement Therapy 55 autoimmune hemolytic anemia 55 adalimumab Humira 55 Cinquil 55 pancreatic neuroendocrine tumors 55 purpura ITP 55 AEG# 55 Treg cell 55 postoperative ileus 55 superficial bladder cancer 55 torsade de pointes 55 metastatic kidney 55 homozygous familial hypercholesterolemia 55 haematological cancers 55 arterial hypertension 55 NSF NFD 55 chemo resistant 55 malignant lymphoma 55 Personalized Immunotherapy 55 topically administered 55 dopaminergic therapy 55 ATL# [001] 55 IGF IR 55 ovarian carcinoma 55 lymphangioleiomyomatosis LAM 55 Gleevec Glivec 55 Diabetic nephropathy 55 pancreatic endocrine 55 liver scarring 55 Hurler Syndrome 55 PF # [002] 55 bronchopulmonary dysplasia 55 Factor VIIa 55 TRO# 55 Acute myeloid leukemia 55 choriocarcinoma 55 Trovax 55 prostate carcinomas 55 choroidal vasculopathy 55 brain malformation 55 leukaemias 55 generalized seizures 55 Arranon 55 JAK STAT signaling 55 stem cell engraftment 55 Phase IIb clinical trials 55 tipifarnib 55 brain lesions 55 NV1FGF 55 KRAS oncogene 55 osteopetrosis 55 overactivation 55 #beta HSD1 55 relapsing remitting MS RRMS 55 Alimta pemetrexed 55 refractory chronic myeloid 55 Cannabinor 55 Chronic Myeloid Leukemia CML 55 neoplastic diseases 55 severe oral mucositis 55 chronic myeloid leukemia CML 55 humanised monoclonal antibody 55 Glycosylation 55 leukemic stem cells 55 thyroid hormone receptor 55 CIMZIA TM certolizumab pegol 55 lupus scleroderma 55 transdifferentiation 55 CYT# potent vascular disrupting 55 interstitial cystitis IC 55 kallikrein 55 eosinophilic esophagitis 55 potent inducer 55 fatal neurodegenerative 55 refractory angina 55 intratumoral injection 55 tyrosine kinase inhibitor 55 histone deacetylase 55 SCCHN 55 huN# DM1 55 Anti VEGF 55 Glioblastoma multiforme 55 PCNSL 55 HGS# 55 basal cell carcinoma BCC 55 lung carcinomas 55 INCB# [001] 55 inhibitor RG# 55 prostate cancer CaP 55 Magnesium deficiency 55 paclitaxel poliglumex 55 PKCi 55 Glioma 55 neuropsychiatric disorder 55 PD LID 55 annexin 55 osteoclast 55 immune modulating 55 leptin deficiency 55 nephrogenic fibrosing dermopathy 55 Benlysta belimumab 55 lymphoproliferative disorder 54 cardiac fibrosis 54 upregulating 54 pegylated liposomal doxorubicin 54 BRAF inhibitors 54 cisplatin chemotherapy 54 TELINTRA 54 investigational therapies 54 glucocorticoid therapy 54 epithelial barrier 54 biomarker identification 54 NOD2 54 atrial arrhythmias 54 MMP inhibitor 54 MyVax ® 54 pulmonary fungal infections 54 von Willebrand 54 VNP#M 54 refractory chronic lymphocytic 54 PNET 54 evaluating Prochymal 54 glioblastoma multiforme GBM 54 myelodysplastic syndrome MDS 54 leukotriene pathway 54 post surgical adhesions 54 alemtuzumab Campath 54 kidney fibrosis 54 acetonide FA 54 neurofibromatosis type 54 Endothelial 54 Parkinson Disease PD 54 adverse cytogenetics 54 autosomal dominant disorder 54 Acute Myelogenous Leukemia 54 inflammatory myofibroblastic tumor 54 relapsing multiple sclerosis 54 renal scarring 54 Progressive Multifocal Leukoencephalopathy 54 mitochondrial disorders 54 infection progressive multifocal 54 gastrointestinal mucositis 54 sunitinib Sutent 54 neuroblastoma tumor 54 Wegener granulomatosis 54 HbF 54 noninfectious uveitis 54 immune suppressing 54 papillary carcinoma 54 aHUS 54 NSCLC tumors 54 cisplatin gemcitabine 54 Cabazitaxel 54 olmesartan 54 Acute Promyelocytic Leukemia 54 bladder carcinoma 54 basal cell nevus syndrome 54 erythema nodosum 54 LymphoStat B belimumab 54 FOLFOX chemotherapy 54 fronto temporal dementia 54 vWD 54 angiogenic therapy 54 Xelox 54 β catenin 54 retinal dystrophies 54 fulminant 54 Immunohistochemical analysis 54 Angiotensin II 54 Tyrosine Kinase Inhibitor 54 autologous hematopoietic stem cell 54 acute leukemias 54 organ transplant rejection 54 verteporfin 54 Olaparib 54 SCD1 54 huntingtin gene 54 Cutaneous T 54 thrombocytopenic 54 biotherapy 54 motor neuron degeneration 54 SIADH 54 p# MAPK 54 Delayed Graft Function 54 Gefitinib 54 vascular disrupting agents 54 transplanted bone marrow 54 Acute Bacterial Sinusitis ABS 54 mycosis fungoides 54 CCR1 54 TG# [003] 54 reperfusion injury 54 liver fibrosis 54 peritoneal carcinomatosis 54 HDACi 54 activin 54 Surgical resection 54 leiomyosarcoma 54 purpura 54 IAP inhibitor 54 myeloid 54 mdx mouse 54 samalizumab 54 erythematosus 54 EGF receptor 54 liver metastasis 54 Myelodysplastic syndromes 54 paroxysmal nocturnal hemoglobinuria PNH 54 peritoneal dialysis PD 54 synovial fibroblasts 54 immune dysregulation 54 Glioblastoma multiforme GBM 54 nephropathic cystinosis 54 BRAF inhibitor 54 beta thalassemia 54 atherosclerotic disease 54 cell lymphoma ALCL 54 FVIIa 54 beta globin gene 54 immunodeficiency diseases 54 histologic subtype 54 Niemann Pick disease 54 antithrombotic therapy 54 glycogen synthase kinase 54 Tasimelteon 54 investigational orally administered 54 Imatinib 54 parathyroid 54 Cell Lymphoma 54 pouchitis 54 mGluR5 antagonist 54 bleomycin 54 microsatellite instability 54 necrotizing enterocolitis NEC 54 prospective multicenter study 54 induce apoptosis 54 malignant phenotype 54 ATL/TV#